Thomas, Mayer & Associés (TMA) advised the biotech firm O&O mdc, an engineering company in ophthalmic medical devices, specialising in Intraoculair Lenses(IOL) and viscoelastic manufacturing, research into new technologies and project development, in the sale of its business to He Vision Group, 何氏眼保健体系, a group of companies specialized in comprehensive eye care system including eye specialists hospital, vision centres, university, research industry centre.
Acquisition of the Anglo-Italian Biotech O&O MDC by the Chinese Group
Cookies are used on this website to improve the user experience and to ensure the efficient functioning of the website.
By using this website, you agree to the use of these cookies please read the Cookies page.
- Recent News: 2025 Summer Interns
- Recent News: Samuel R. Marchese Joins Warshaw Burstein as Partner in the Real Estate Group
- Recent News: The New Rulebook: How Regulatory Clarity is Reshaping the Digital Asset Economy
- Recent News: Prof. Dr. Arnold Vahrenwald has joined Stach Rechtsanwälte
- Recent News: James A. Wolff Authors Article On The Rise of AI Litigation in the New York Law Journal